CMS Ventures

CMS Ventures, established in 2020, is the corporate venture arm of China Medical System Holdings, located in Cambridge, United Kingdom. The firm specializes in the biotechnology and life sciences sectors, focusing on therapeutics, diagnostics, medical devices, and digital health. CMS Ventures actively engages with seed-stage, early-stage, and later-stage companies, providing not only financial investment but also essential support through evaluation, coaching, mentoring, and advisory services. The firm aims to foster growth within the biotech and life sciences ecosystem, primarily within the United Kingdom.

James Stearns

Managing Director

3 past transactions

Build on Bitcoin

Seed Round in 2024
Build on Bitcoin is a hybrid Layer-2 network Bitcoin blockchain

Pact

Seed Round in 2022
Pact is a fintech platform launched in 2021 that specializes in offering deep liquidity and low transaction fees for financial transactions. It operates as a non-custodial and decentralized platform, integrating financial assets to create a secure environment for users of varying wealth and experience levels. Pact's accessible smart contract functionality allows for efficient and cost-effective transactions, facilitating quick swaps within the cryptocurrency market. The platform is designed to serve as a central hub for liquidity on Algorand, enhancing the overall user experience in decentralized finance.

Qureight

Seed Round in 2021
Qureight is an imaging analytics company focused on enhancing drug development through its clinical data curation and analytics platform. The company utilizes artificial intelligence and advanced processing tools to analyze large clinical datasets, particularly in the context of respiratory diseases such as Idiopathic Pulmonary Fibrosis and lung cancer. By collaborating with hospitals, pharmaceutical companies, and software developers, Qureight aims to structure medical images and associated clinical metadata, facilitating the identification of novel biomarkers and a deeper understanding of complex diseases and potential therapeutic strategies. Through these efforts, Qureight seeks to drive innovation in healthcare and improve patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.